Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne-Brita Knapskog

Showing results (51-60 of 79) with videos related to

Pageof 8
Sort By:
Frontiers in Neurology|August 23, 2021
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST StudyStina Aam, Mari Nordbø Gynnild, Ragnhild Munthe-Kaas, et al.
Plos One|October 17, 2017
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesisKarin Persson, Rannveig Sakshaug Eldholm, Maria Lage Barca, et al.
Brain and Behavior|April 10, 2024
Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementiaKarin Persson, Maria L Barca, Trine Holt Edwin, et al.
International Psychogeriatrics|December 18, 2018
Cortisol levels among older people with and without depression and dementiaMaria Lage Barca, Rannveig S Eldholm, Karin Persson, et al.
Frontiers in Aging Neuroscience|June 12, 2023
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trialLuiza Jadwiga Chwiszczuk, Monica Haraldseid Breitve, Bjørn-Eivind Bordewick Kirsebom, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Sex-specific associations of kynurenic acid with neopterin in Alzheimer's diseaseAnne-Brita Knapskog, Trine Holt Edwin, Per Magne Ueland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2023
Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's diseaseAnne-Brita Knapskog, Mari Aksnes, Trine Holt Edwin, et al.
Arquivos De Neuro-Psiquiatria|September 25, 2014
Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in ADNarahyana Bom de Araujo, Helena Sales Moraes, Heitor Silveira, et al.
BMC Neurology|November 28, 2018
The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort studyPernille Thingstad, Torunn Askim, Mona K Beyer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 14, 2020
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's diseaseTrine Holt Edwin, Kristi Henjum, Lars N G Nilsson, et al.
Pageof 8

Showing results (51-60 of 79) with videos related to

Sort By:
Pageof 8
Frontiers in Neurology|August 23, 2021
The Impact of Vascular Risk Factors on Post-stroke Cognitive Impairment: The Nor-COAST StudyStina Aam, Mari Nordbø Gynnild, Ragnhild Munthe-Kaas, et al.
Plos One|October 17, 2017
MRI-assessed atrophy subtypes in Alzheimer's disease and the cognitive reserve hypothesisKarin Persson, Rannveig Sakshaug Eldholm, Maria Lage Barca, et al.
Brain and Behavior|April 10, 2024
Regional MRI volumetry using NeuroQuant versus visual rating scales in patients with cognitive impairment and dementiaKarin Persson, Maria L Barca, Trine Holt Edwin, et al.
International Psychogeriatrics|December 18, 2018
Cortisol levels among older people with and without depression and dementiaMaria Lage Barca, Rannveig S Eldholm, Karin Persson, et al.
Frontiers in Aging Neuroscience|June 12, 2023
The ANeED study - ambroxol in new and early dementia with Lewy bodies (DLB): protocol for a phase IIa multicentre, randomised, double-blinded and placebo-controlled trialLuiza Jadwiga Chwiszczuk, Monica Haraldseid Breitve, Bjørn-Eivind Bordewick Kirsebom, et al.
Alzheimer'S Research & Therapy|July 27, 2024
Sex-specific associations of kynurenic acid with neopterin in Alzheimer's diseaseAnne-Brita Knapskog, Trine Holt Edwin, Per Magne Ueland, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 2, 2023
Higher concentrations of kynurenic acid in CSF are associated with the slower clinical progression of Alzheimer's diseaseAnne-Brita Knapskog, Mari Aksnes, Trine Holt Edwin, et al.
Arquivos De Neuro-Psiquiatria|September 25, 2014
Impaired cognition in depression and Alzheimer (AD): a gradient from depression to depression in ADNarahyana Bom de Araujo, Helena Sales Moraes, Heitor Silveira, et al.
BMC Neurology|November 28, 2018
The Norwegian Cognitive impairment after stroke study (Nor-COAST): study protocol of a multicentre, prospective cohort studyPernille Thingstad, Torunn Askim, Mona K Beyer, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)|December 14, 2020
A high cerebrospinal fluid soluble TREM2 level is associated with slow clinical progression of Alzheimer's diseaseTrine Holt Edwin, Kristi Henjum, Lars N G Nilsson, et al.
Pageof 8